Syncom Formulations is trading at INR 18.01, up 5.75%, after rising from INR 17.56 on August 25, 2026; no reliable company-specific announcement dated August 26–27 directly explains the move.
- Latest identifiable catalysts were strong June-quarter results, including a 57.71% year-on-year PAT increase, and a proposed ₹0.10 dividend, both announced earlier in August.
- The provided market context shows no meaningful broad-index move to establish a global explanation.
- Confidence is low.